R

Researcher Profile

Robert J Jones

0000-0002-2904-6980

2

Publications

358

Citations

10

Co-Authors

2

Active Years

Publications

Journal Article The Lancet Aug 01, 2025

Talazoparib plus enzalutamide in men with HRR-deficient metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trial

Karim Fizazi · Arun A Azad · Nobuaki Matsubara · Joan Carles +16 more

10.1016/s0140-6736(25)00683-x 20 citations

Open Access Journal Article The Lancet Jan 01, 2022

Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol

Gerhardt Attard · Laura Murphy · Noel W Clarke · William Cross +149 more

10.1016/s0140-6736(21)02437-5 338 citations

Publication Timeline

2025

1

2022

1

Frequent Co-Authors

Richard Shaffer

Christopher C Parker